Subtherapeutic Rifampicin Concentration Is Associated With Unfavorable Tuberculosis Treatment Outcomes

Ramachandran, Geetha and Chandrasekaran, Padmapriyadarshini and Gaikwad, Sanjay and Agibothu Kupparam, Hemanth Kumar and Thiruvengadam, Kannan and Gupte, Nikhil and Paradkar, Mandar and Dhanasekaran, Kavitha and Sivaramakrishnan, Gomathi Narayan and Kagal, Anju and Thomas, Beena and Pradhan, Neeta and Kadam, Dileep and Hanna, Luke Elizabeth and Balasubramanian, Usha and Kulkarni, Vandana and Murali, Lakshmi and Golub, Jonathan and Gupte, Akshay and Shivakumar, Shri Vijay Bala Yogendra and Swaminathan, Soumya and Dooley, Kelly E and Gupta, Amita and Mave, Vidya (2019) Subtherapeutic Rifampicin Concentration Is Associated With Unfavorable Tuberculosis Treatment Outcomes. Clinical Infectious Diseases, 70 (7). pp. 1463-1470. ISSN 1058-4838

Archive 202072.pdf - Published Version Download (364kB)

Affiliation:	ICMR-National Institute for Research in Tuberculosis
Item Type:	Article
Uncontrolled Keywords:	tuberculosis; pharmacokinetics; drug concentrations; subtherapeutic concentrations; unfavorable treatment outcomes.
Subjects:	Tuberculosis > Laboratory Research > Biochemical Tuberculosis > Laboratory Research > Pharmacological
Divisions:	Basic Science Research > Biochemistry Basic Science Research > Clinical Pharmacology
Depositing User:	Dr. Rathinasabapati R
Date Deposited:	24 Nov 2022 07:31
Last Modified:	24 Nov 2022 07:31
URI:	http://eprints.nirt.res.in/id/eprint/1804

Actions (login required)

View Item